Magnesium decanoate

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 581927

CAS#: 42966-30-3

Description: Magnesium decanoate is a biochemical.


Chemical Structure

img
Magnesium decanoate
CAS# 42966-30-3

Theoretical Analysis

MedKoo Cat#: 581927
Name: Magnesium decanoate
CAS#: 42966-30-3
Chemical Formula: C20H38MgO4
Exact Mass: 366.26
Molecular Weight: 366.820
Elemental Analysis: C, 65.49; H, 10.44; Mg, 6.63; O, 17.45

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Magnesium decanoate; Magnesium caprate; Decanoic acid, magnesium salt; Magnesium di(decanoate)

IUPAC/Chemical Name: magnesium decanoate

InChi Key: WWRYOAYBSQIWNU-UHFFFAOYSA-L

InChi Code: InChI=1S/2C10H20O2.Mg/c2*1-2-3-4-5-6-7-8-9-10(11)12;/h2*2-9H2,1H3,(H,11,12);/q;;+2/p-2

SMILES Code: CCCCCCCCCC([O-])=O.CCCCCCCCCC([O-])=O.[Mg+2]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 366.82 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Matulyte I, Marksa M, Ivanauskas L, Kalvėnienė Z, Lazauskas R, Bernatoniene J. GC-MS Analysis of the Composition of the Extracts and Essential Oil from Myristica fragrans Seeds Using Magnesium Aluminometasilicate as Excipient. Molecules. 2019 Mar 18;24(6). pii: E1062. doi: 10.3390/molecules24061062. PubMed PMID: 30889896; PubMed Central PMCID: PMC6471610.

2: Ballistreri A, Giuffrida M, Guglielmino SP, Carnazza S, Ferreri A, Impallomeni G. Biosynthesis and structural characterization of medium-chain-length poly(3-hydroxyalkanoates) produced by Pseudomonas aeruginosa from fatty acids. Int J Biol Macromol. 2001 Aug 20;29(2):107-14. PubMed PMID: 11518582.

3: Makhmudov TM, Makhsumov MN, Mazgutov VZ. [Anabolic effects of sodium selenite, vitamin E and retabolil in experimental hypotrophy induced by a pesticide]. Vopr Pitan. 1989 May-Jun;(3):61-4. Russian. PubMed PMID: 2552678.

4: Sinitsyn SP. [Correction of metabolic disorders of the myocardium in acute myocardial infarct as an important factor in preventing the development of circulatory insufficiency]. Kardiologiia. 1985 Jul;25(7):111-2. Russian. PubMed PMID: 2414506.

5: Leshchinskiĭ LA, Trusov VV, Anisimova LV, Barbakova AA. [Correction of protein metabolism in myocardial infarction according to the results of radionuclide studies with 131-albumin during during treatment with a number of drugs (retabolyl, methyluracil, panangin, strophanthin) and combinations of them]. Kardiologiia. 1984 Mar;24(3):35-9. Russian. PubMed PMID: 6727091.

6: Rzheusskaia LD. [Disintoxication therapy of patients with nonspecific inflammatory diseases of the female genital organs]. Akush Ginekol (Mosk). 1977 Apr;(4):30-4. Russian. PubMed PMID: 883594.